What a brutal six months it’s been for Illumina. The stock has dropped 33.6% and now trades at $89.03, rattling many ...

Illumina Inc. (NASDAQ: ILMN), aligned with its commitments to advance the power of genomics, today published its ... a Buy rating on the stock and a $135 price target. The firm’s confidence ...

Accretion Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Smallcap on the NSE, currently has its share price at ₹77.95. The stock has experienced fluctuations today ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), The Walt Disney Co ...

GRAIL, Inc. was spun off from Illumina in 2024 and offers a promising multi-cancer early detection test called Galleri. Click ...

With the global demand for semiconductors soaring, many are eager to know the future of TSM stock price. Currently, TSM stock is trading at $214.10 per share, with a market capitalization ...

In a report released today, Kyle Mikson CFA from Canaccord Genuity maintained a Hold rating on Illumina (ILMN – Research Report), with a price target of $99.00. The company’s ...

The share price is still 19.2% lower year to date, as well as down 29.5% since its 52-week high on Dec. 17, 2024. Tesla stock has gained 91.3% over the past year, leaving plenty of investors drawn ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...